GMJ Briefs
MHRA Registry Documents Full Scope of Emergency Device Exemptions in 2024
MHRA's 2024 registry documents active, expired, and cancelled medical device exemptions to support evidence-based healthcare decision-making.
What Healthcare Professionals Should Know About Platform Trials in Neurology
Platform trials enable simultaneous evaluation of multiple neurological treatments, potentially accelerating breakthroughs for Alzheimer's, Parkinson's, and motor neuron disease.
Takeaway: Regulatory Agencies Split on New Alzheimer’s Drugs as Hope Meets Uncertainty
3 key insights on Alzheimer's drug regulation: 1️⃣ Major agencies reach different conclusions on same treatments 2️⃣ New drugs show…
What Clinicians Must Know About Paracetamol Poisoning: Beyond Acute Liver Injury
Paracetamol poisoning demands integrated mental health care, not just toxicology management, to prevent repeat attempts.
Three Ways AI is Reshaping Pancreatic Cancer Diagnosis and Clinical Equity
Open-source AI tool combines superior accuracy with global accessibility to transform pancreatic cancer diagnosis and reduce diagnostic inequality.
US Drug Shortages Hit Decade Low, Yet Critical Supply Chain Vulnerabilities Remain
US drug shortages fell 23% in 2025, but supply chain vulnerabilities in cancer medications and generics persist.
What Transplant Candidates Should Know About Geographic Access Disparities
New research identifies persistent geographic barriers to lung transplant access and the need for further policy refinements to achieve equitable…
Millions Converge at World Cup: How Stadium Crowds Amplify Respiratory Disease Spread
Millions of international spectators at World Cup events create optimal conditions for rapid respiratory disease transmission.